Print

ZIOPHARM, Inc. Reports Third Quarter Financial Results and Highlights  
11/4/2011 6:29:29 AM

NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a drug development company employing small molecule and synthetic biology approaches to cancer therapy, today reported financial results and key highlights for the three months ended September 30, 2011.
//-->